JPWO2021046398A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021046398A5
JPWO2021046398A5 JP2022515099A JP2022515099A JPWO2021046398A5 JP WO2021046398 A5 JPWO2021046398 A5 JP WO2021046398A5 JP 2022515099 A JP2022515099 A JP 2022515099A JP 2022515099 A JP2022515099 A JP 2022515099A JP WO2021046398 A5 JPWO2021046398 A5 JP WO2021046398A5
Authority
JP
Japan
Prior art keywords
peptide
hrc
antiviral
fip
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022515099A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551813A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/049473 external-priority patent/WO2021046398A2/en
Publication of JP2022551813A publication Critical patent/JP2022551813A/ja
Publication of JPWO2021046398A5 publication Critical patent/JPWO2021046398A5/ja
Pending legal-status Critical Current

Links

JP2022515099A 2019-09-04 2020-09-04 麻疹に対する併用抗ウイルス療法 Pending JP2022551813A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962895752P 2019-09-04 2019-09-04
US62/895,752 2019-09-04
US202062988286P 2020-03-11 2020-03-11
US62/988,286 2020-03-11
US202063009883P 2020-04-14 2020-04-14
US63/009,883 2020-04-14
PCT/US2020/049473 WO2021046398A2 (en) 2019-09-04 2020-09-04 Combination antiviral therapy for measles

Publications (2)

Publication Number Publication Date
JP2022551813A JP2022551813A (ja) 2022-12-14
JPWO2021046398A5 true JPWO2021046398A5 (zh) 2023-09-13

Family

ID=74853434

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022515099A Pending JP2022551813A (ja) 2019-09-04 2020-09-04 麻疹に対する併用抗ウイルス療法

Country Status (6)

Country Link
US (1) US20230014151A1 (zh)
EP (1) EP4025586A4 (zh)
JP (1) JP2022551813A (zh)
CN (1) CN114729007A (zh)
IL (1) IL291091A (zh)
WO (1) WO2021046398A2 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022159372A1 (en) * 2021-01-22 2022-07-28 Decoy Therapeutics, Inc. Methods and compositions for treating infections
WO2023150375A2 (en) * 2022-02-07 2023-08-10 Decoy Therapeutics Inc. Methods and compositions for treating covid infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2261380B1 (en) * 2003-11-04 2013-07-17 The Administrators of the Tulane Educational Fund Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
US20130196903A1 (en) * 2010-08-11 2013-08-01 Jv Bio Srl Multimeric Inhibitors of Viral Fusion and Uses Thereof
US10172961B2 (en) * 2014-05-07 2019-01-08 Cornell University Inhibitors of fusion between viral and cell membranes as well as compositions and methods of using them

Similar Documents

Publication Publication Date Title
US10259848B2 (en) Compositions and methods comprising hydrocarbon-stapled polypeptides
US7456251B2 (en) HIV fusion inhibitor peptides with improved biological properties
US20230086093A1 (en) Mutant rsv f protein and use thereof
US20230399364A1 (en) Immunogenic Coronavirus Fusion Proteins and Related Methods
WO2023123722A1 (zh) 一种抗冠状病毒的多肽、其衍生物及其应用
JPWO2021046398A5 (zh)
US20030219451A1 (en) Stable helical C peptides and uses therefor
US20070134221A1 (en) Stabilizing peptides
US20230140025A1 (en) Vectors for Producing Virus-Like Particles and Uses Thereof
WO2007107597A2 (en) Immunogenic construct and a method for the prophylactic or therapeutic treatment of aids
CN104311644A (zh) 多肽、提高多肽稳定性的方法、药物组合物以及多肽在制备药物中的用途
WO2024130061A1 (en) Immunogenic ebolavirus fusion proteins and related methods
WO2024059149A2 (en) Immunogenic coronavirus fusion proteins and related methods
CN117062829A (zh) 用于包埋covid-19疫苗的破伤风疫苗平台
EP1500662A2 (en) Stabilizing peptides
JPWO2021216891A5 (zh)